"Drs. Brett Miles and Marshall Posner - FDA Awards Grant for Phase 2 Study of Immunotherapy Drug used in HPV-Associated Head and Neck Cancer"

Mount Sinai Scientists Create AI-Powered Tool to Improve Cancer Tissue Analysis

Combination Therapy Improves Outcomes for Advanced Triple-Negative Breast Cancer

Mount Sinai Researchers Pioneer First Targeted Therapy for Rare T-Cell Lymphoma After CAR T Treatment

Mount Sinai Receives $4 Million Grant From American Cancer Society to Launch Cancer Health Research Center

Mount Sinai Researchers Engineer Rare Immune Cells to Create Powerful New Cancer Vaccine

Mount Sinai Researchers Discover Link Between Metabolism and Protective Effect of Breastfeeding Against Breast Cancer

Mount Sinai Researcher Publishes Landmark Studies Advancing Treatment for Rare and Aggressive Lymphoma

Mount Sinai and Cancer Research Institute Team Up to Improve Patient Outcomes in Immunotherapy

Mount Sinai Study Advances Understanding of Personalized Vaccines for Bladder Cancer

Mount Sinai Mammogram May® Spotlights Breast Cancer Screening Supported by Artificial Intelligence in Life-Saving Early Detection

Mount Sinai Researchers Discover How Melanoma May Spread to the Brain